UPDATE 5-GE inks $21 bln biopharma sale to Danaher in U-turn under Culp
February 25, 2019 at 14:37 PM EST
* Danaher gains as deal boosts capability into drug development market
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|